Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 2
1997 1
1998 1
1999 1
2000 3
2002 4
2003 1
2004 2
2005 5
2006 4
2007 7
2008 11
2009 17
2010 16
2011 7
2012 7
2013 14
2014 16
2015 14
2016 5
2017 6
2018 7
2019 4
2020 1
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

138 results
Results by year
Filters applied: . Clear all
Page 1
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study.
Barlesi F, Vansteenkiste J, Spigel D, Ishii H, Garassino M, de Marinis F, Özgüroğlu M, Szczesna A, Polychronis A, Uslu R, Krzakowski M, Lee JS, Calabrò L, Arén Frontera O, Ellers-Lenz B, Bajars M, Ruisi M, Park K. Barlesi F, et al. Among authors: uslu r. Lancet Oncol. 2018 Nov;19(11):1468-1479. doi: 10.1016/S1470-2045(18)30673-9. Epub 2018 Sep 24. Lancet Oncol. 2018. PMID: 30262187 Clinical Trial.
[Cancer and palliative care].
Uslu R, Uyar M. Uslu R, et al. Agri. 2005 Jul;17(3):5-10. Agri. 2005. PMID: 16158337 Free article. Review. Turkish.
The Impact of Subtype Distribution in Inflammatory Breast Cancer Outcome.
Çakar B, Sürmeli Z, Öner PG, Yelim ES, Karabulut B, Uslu R. Çakar B, et al. Among authors: uslu r. Eur J Breast Health. 2018 Oct 1;14(4):211-217. doi: 10.5152/ejbh.2018.4170. eCollection 2018 Oct. Eur J Breast Health. 2018. PMID: 30288495 Free PMC article.
138 results